Study to Reduce Antibiotic prescription in childhood Pneumonia: implementation of a validated decision rule

Study to Reduce Antibiotic prescription in childhood Pneumonia: implementation of a validated decision rule - Study to Reduce Antibiotic prescription in childhood Pneumonia

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON47230

Enrollment

900

Registered

2015-03-04

Start date

2016-03-01

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lower respiratory tract infections pneumonia

Interventions

Clinical decision rule for the individual risk for CAP and for other SBI guiding a targeted approach for antibiotic prescription

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: children aged 1 month - 5 years (60 months) with fever and signs suspected of pneumonia

Exclusion criteria

Exclusion criteria: 1) comorbidity resulting in higher risk of (complications of) infectious diseases, i.e. cardiac, pulmonary, renal, neurologic disease or immunodeficiency 2)children with obvious single infectious focus (cutaneous, otitis media, rhinitis) 3) children with parents not able to understand or to act on safety-net instructions

Design outcomes

Primary

Measure	Time frame
Rate of narrowspectrum antibiotic prescriptions and uneventful recoveries after CAP	—

Secondary

Measure	Time frame
Compliance to the rule; Safetyendpoints	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)